Baxter International company profile

BAX · NYSE · USD

Compare Baxter International
$25.39Change from previous close: 0.00%Absolute change: +$0.00

Close · November 20, 2026

Company profile

Baxter International has 37,500 employees and is headquartered in Deerfield, United States.

Sterile intravenous solutions, infusion systems and parenteral nutrition therapies are among the products hospitals and patients associate with Baxter. The company also makes surgical hemostat and sealant products, smart bed systems, patient monitoring devices, inhaled anesthetics and generic injectable pharmaceuticals, organized in three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Its products reach hospitals, nursing homes, dialysis centers, ambulatory surgery centers and patients at home, sold through a direct sales force, independent distributors and drug wholesalers. Markets include the United States, Western Europe, Canada, Japan, Australia, New Zealand, Eastern Europe, Latin America, Asia, the Middle East and Africa.

In the fiscal year ended December 2025, Baxter reported revenue of $11.2 billion, up 5.7% from the previous year, and a net loss of $957 million. The United States accounted for 54.4% of revenue, while Western Europe, Canada, Japan, Australia and New Zealand together accounted for 33.2%. The company had 37,500 employees and is headquartered in Deerfield, Illinois, where it was incorporated in 1931.

Company facts

Industry
Medical Instruments & Supplies
Headquarters
One Baxter Parkway, 60015, Deerfield
Employees
37,500
Chief executive
Andrew Hider
Founded
1931
Fiscal year
January - December
Listing
BAX · NYSE
Indices
S&P 500
Currency
USD
ISIN
US0718131099
Website
baxter.com

Baxter International and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Baxter InternationalBAXUnited States$13.14B37,5007.6%—
SolventumSOLVUnited States$14.36B20,5845.9%94.9
Cooper CompaniesCOOUnited States$11.2B15,00012.9%20.2
Align TechnologyALGNUnited States$10.94B20,18019.6%22.6
RepligenRGENUnited States$10.89B2,0008.1%—
AvantorAVTRUnited States$10.06B13,5008.0%29.7

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Baxter International with its competitors